what's the difference in ozempic and semaglutide vs Rybelsus for Weight Loss: Which Treatment Is Better for You? what's the difference between compounded

From meal planning to workout schedules, routines create structure

benefits of treating PPL living with #obesity #heartdisease some intriguing NNT data for primary and secondary caregivers composite endpoints from the SELECT trial @novonordisk with #Semaglutide #Wegovy The STEP-9 trial evaluated the impact of Semaglutide 2.4mg once weekly in PPL with #obesity and knee osteoarthritis

In contrast, Wegovy follows different guidelinesopened pens remain viable for only 28 days

Lack of weight loss or weight regain : If you experience persistent hunger and have not achieved meaningful weight loss (less than 5% body weight) after 3 months at a stable maintenance dose, or if you begin regaining weight, medical evaluation is warranted

Those who may warrant closer monitoring include: Individuals with pre-existing tachycardia or arrhythmias, such as atrial fibrillation or supraventricular tachycardia Patients with hyperthyroidism, which independently elevates resting heart rate Those taking other medicines that may increase heart rate, including sympathomimetics (such as decongestants and stimulants), serotoninnoradrenaline reuptake inhibitors (SNRIs), tricyclic antidepressants, or beta-2 agonists used in asthma management Individuals with a history of heart failure, where even modest increases in heart rate may affect cardiac output and symptom burden though it should be noted that increased cardiovascular risk in this group is based on clinical prudence rather than confirmed harm with GLP-1 receptor agonists Patients receiving higher doses of retatrutide, given the dose-dependent nature of the effect observed in Phase 2 trials Age and baseline cardiovascular health are also relevant considerations